31791660|t|Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
31791660|a|Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are the 2 most common causes of dementia. We compared the regional metabolism on 18F-fluorodeoxyglucose positron emission tomography (PET) among 21 control subjects and cognitively impaired patients due to DLB (N = 63) and AD (N = 38). All participants underwent 18F-Florbetaben (FBB) PET, and all DLB patients had abnormality on dopamine transporter PET. Both the FBB-positive DLB (N = 38) and FBB-negative DLB (N = 25) groups had increased metabolism in the bilateral central cerebellum, posterior putamen, and somatomotor cortices compared with the control and AD groups. Compared with the control group, the DLB and AD groups commonly exhibited hypometabolism in the bilateral lateral temporal, temporo-parietal junction, posterior cingulate, and precuneus cortices. Both DLB groups had additional hypometabolism in the bilateral thalami and dorsolateral prefrontal cortices, whereas the AD group did in the bilateral entorhinal cortices and hippocampi. Our results suggest that hypermetabolism in the somatomotor cortex, posterior putamen, or central cerebellum could be a useful imaging biomarker for detecting DLB patients, while entorhinal/hippocampal hypometabolism could be a specific biomarker for AD.
31791660	23	48	dementia with Lewy bodies	Disease	MESH:D020961
31791660	53	72	Alzheimer's disease	Disease	MESH:D000544
31791660	99	118	Alzheimer's disease	Disease	MESH:D000544
31791660	120	122	AD	Disease	MESH:D000544
31791660	128	153	dementia with Lewy bodies	Disease	MESH:D020961
31791660	155	158	DLB	Disease	MESH:D020961
31791660	192	200	dementia	Disease	MESH:D003704
31791660	241	263	18F-fluorodeoxyglucose	Chemical	MESH:D019788
31791660	329	349	cognitively impaired	Disease	MESH:D003072
31791660	350	358	patients	Species	9606
31791660	366	369	DLB	Disease	MESH:D020961
31791660	383	385	AD	Disease	MESH:D000544
31791660	423	438	18F-Florbetaben	Chemical	MESH:C527756
31791660	440	443	FBB	Chemical	MESH:C527756
31791660	458	461	DLB	Disease	MESH:D020961
31791660	462	470	patients	Species	9606
31791660	490	510	dopamine transporter	Gene	6531
31791660	525	528	FBB	Chemical	MESH:C527756
31791660	538	541	DLB	Disease	MESH:D020961
31791660	555	558	FBB	Chemical	MESH:C527756
31791660	568	571	DLB	Disease	MESH:D020961
31791660	724	726	AD	Disease	MESH:D000544
31791660	772	775	DLB	Disease	MESH:D020961
31791660	780	782	AD	Disease	MESH:D000544
31791660	809	823	hypometabolism	Disease	
31791660	936	939	DLB	Disease	MESH:D020961
31791660	962	976	hypometabolism	Disease	
31791660	1052	1054	AD	Disease	MESH:D000544
31791660	1277	1280	DLB	Disease	MESH:D020961
31791660	1281	1289	patients	Species	9606
31791660	1320	1334	hypometabolism	Disease	
31791660	1369	1371	AD	Disease	MESH:D000544
31791660	Association	MESH:D020961	6531
31791660	Positive_Correlation	MESH:C527756	MESH:D020961

